Welcome to our dedicated page for AMHCW news (Ticker: AMHCW), a resource for investors and traders seeking the latest updates and insights on AMHCW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AMHCW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AMHCW's position in the market.
Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHC) announced that its stockholders approved the business combination with Jasper Therapeutics, Inc. on September 22, 2021, with 74.9% voting in favor out of 9,872,643 total votes. Following the approval, 9,262,099 shares of AMHC Class A common stock were redeemed, allowing Jasper to waive the $130 million cash requirement. The business combination is expected to close around September 24, 2021, and shares of the combined company will begin trading on Nasdaq by September 27, 2021.
